Read More News Why Western Alliance Stock (WAL) Is Rising By Henry Khederian July 18, 11:05 AM Western Alliance Bancorporation (NYSE: WAL) shares are trading higher by 6.9% to $42.58 Tuesday morning. WAL
Read More Contracts Equities General Markets Movers News Why KBR Shares Are Surging Today By Nabaparna Bhattacharya July 24, 7:26 AM KBR, Inc. (NYSE: KBR) has bagged a contract worth up to $1.9 billion for KBR
Read More Analyst Ratings Initiation News Price Target FBN Securities Initiates Coverage On Informatica with Outperform Rating, Announces Price Target of $35 By Benzinga Newsdesk September 13, 9:46 AM FBN Securities analyst Shebly Seyrafi initiates coverage on Informatica (NYSE:INFA) with a Outperform rating and announces Price Target of $35. INFA
Read More Biotech General News Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment In Phase 3 REBUILD Study For INOpulse In Fibrotic Interstitial Lung Disease; Company Expects To Report Top-Line Results From This Study In Mid-2023 By Happy Mohamed May 11, 8:32 AM Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today BLPH